Nuvalent Inc (NUVL) poses a Brand-New Opportunity for Investors with beta value of 1.31

Shaun Noe

As on Wednesday, Nuvalent Inc (NASDAQ: NUVL) got off with the flyer as it spiked 9.90% to $106.82, before settling in for the price of $97.2 at the close. Taking a more long-term approach, NUVL posted a 52-week range of $55.53-$112.88.

The Healthcare sector firm’s twelve-monthly sales growth has been -74.22% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -74.22%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -45.43%. This publicly-traded company’s shares outstanding now amounts to $66.84 million, simultaneously with a float of $47.77 million. The organization now has a market capitalization sitting at $7.77 billion. At the time of writing, stock’s 50-day Moving Average stood at $102.35, while the 200-day Moving Average is $83.77.

Nuvalent Inc (NUVL) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Nuvalent Inc’s current insider ownership accounts for 34.29%, in contrast to 76.31% institutional ownership. According to the most recent insider trade that took place on Jan 06 ’26, this organization’s Chief Scientific Officer sold 2,664 shares at the rate of 97.17, making the entire transaction reach 258,848 in total value, affecting insider ownership by 65,888. Preceding that transaction, on Jan 05 ’26, Company’s Chief Scientific Officer sold 2,496 for 97.32, making the whole transaction’s value amount to 242,905. This particular insider is now the holder of 68,552 in total.

Nuvalent Inc (NUVL) Earnings and Revenue Records

Nuvalent Inc’s EPS decrease for this current 12-month fiscal period is -45.43% and is forecasted to reach -5.77 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -2.60% through the next 5 years, which can be compared against the -74.22% growth it accomplished over the previous five years trading on the market.

Nuvalent Inc (NASDAQ: NUVL) Trading Performance Indicators

Let’s observe the current performance indicators for Nuvalent Inc (NUVL). It’s Quick Ratio in the last reported quarter now stands at 10.73.

In the same vein, NUVL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.32, a figure that is expected to reach -1.48 in the next quarter, and analysts are predicting that it will be -5.77 at the market close of one year from today.

Technical Analysis of Nuvalent Inc (NUVL)

Through scrutinizing the latest numbers posted by the [Nuvalent Inc, NUVL], it can be observed that its last 5-days Average volume of 0.7 million was lower the volume of 0.78 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 41.16% While, its Average True Range was 61.79.

Raw Stochastic average of Nuvalent Inc (NUVL) in the period of the previous 100 days is set at 85.29%, which indicates a major fall in contrast to 87.34% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.68 that was lower than 3.94 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.